United Arab Emirates Antiviral Drugs Market to 2032
Overview
The United Arab Emirates Antiviral Drugs Market is expected to reach a 307.48 USD Million by 2032 and is projected to grow at a CAGR of 4.02% from 2025 to 2032.
Revenue, 2024 (USD Million)
245.51
Forecast, 2032 (USD Million)
307.48
CAGR, 2024 - 2032
4.02%
Report Coverage
United Arab Emirates
United Arab Emirates Antiviral Drugs Market 2018-2032 USD Million
United Arab Emirates Antiviral Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 245.51 USD Million
- Projected Market Size (2032): 307.48 USD Million
- CAGR (2025-2032): 4.02%
Key Findings of United Arab Emirates Antiviral Drugs Market
- The United Arab Emirates Antiviral Drugs Market was valued at 245.51 USD Million in 2024.
- The United Arab Emirates Antiviral Drugs Market is likely to grow at a CAGR of 4.02% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Topical in Products Segment accounted for the largest share of the market with a revenue of 245.51 USD Million
- The fastest growing segment Adult in Patient Segment grew Fastest with a CAGR of 4.56% during the forecast period from 2024 to 2032.
United Arab Emirates Antiviral Drugs Market Scope
United Arab Emirates Antiviral Drugs Market Segmentation & Scope
End User
- Others
- Home Healthcare
- Clinics
- Ambultatory Centres
- Speciality Centers
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Products
- Parenteral
- Oral
- Topical
Drug
- Branded
- Generic
Indication
- Others
- Coronavirus Infection
- Respiratory Syncytial Virus
- Hepatitis B Virus
- Varicella-Zoster Virus (VZV)
- Human Cytomegalovirus (HCMV)
- Herpes Simplex Virus
- Hepatitis C Virus
- Human Immunodeficiency Virus (HIV)
- Influenza
Patient
- Adult
- Child
- Geriatric
United Arab Emirates Antiviral Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 245.51 USD Million |
| Market Value in 2032 | 307.48 USD Million |
| CAGR (2025-2032) | 4.02% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Products,Drug,Indication,Patient |
Regional Insights:
-
Leading Market (2024-2032): United Arab Emirates, leading in terms of revenue 245.51 USD Million in 2024
- Key Country: United Arab Emirates, leading in terms of revenue with value of 245.51 USD Million in 2024.
Segments and Scope
-
United Arab Emirates Antiviral Drugs Market to 2032, By End User
- Hospitals is the largest segment in United Arab Emirates Antiviral Drugs Market to 2032 with a revenue of 177.21 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in United Arab Emirates Antiviral Drugs Market to 2032 with a Growth rate of 4.49 % in forecast period 2025-2032.
-
United Arab Emirates Antiviral Drugs Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in United Arab Emirates Antiviral Drugs Market to 2032 with a revenue of 180.06 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in United Arab Emirates Antiviral Drugs Market to 2032 with a Growth rate of 4.38 % in forecast period 2025-2032.
-
United Arab Emirates Antiviral Drugs Market to 2032, By Products
- Topical is the largest segment in United Arab Emirates Antiviral Drugs Market to 2032 with a revenue of 245.51 USD Million in the year 2024.
- Oral is the Fastest growing segment in United Arab Emirates Antiviral Drugs Market to 2032 with a Growth rate of 4.02 % in forecast period 2025-2032.
-
United Arab Emirates Antiviral Drugs Market to 2032, By Drug
- Generic is the largest segment in United Arab Emirates Antiviral Drugs Market to 2032 with a revenue of 196.72 USD Million in the year 2024.
- Generic is the Fastest growing segment in United Arab Emirates Antiviral Drugs Market to 2032 with a Growth rate of 4.18 % in forecast period 2025-2032.
-
United Arab Emirates Antiviral Drugs Market to 2032, By Indication
- Influenza is the largest segment in United Arab Emirates Antiviral Drugs Market to 2032 with a revenue of 152.13 USD Million in the year 2024.
- Influenza is the Fastest growing segment in United Arab Emirates Antiviral Drugs Market to 2032 with a Growth rate of 4.51 % in forecast period 2025-2032.
-
United Arab Emirates Antiviral Drugs Market to 2032, By Patient
- Adult is the largest segment in United Arab Emirates Antiviral Drugs Market to 2032 with a revenue of 173.34 USD Million in the year 2024.
- Adult is the Fastest growing segment in United Arab Emirates Antiviral Drugs Market to 2032 with a Growth rate of 4.56 % in forecast period 2025-2032.
United Arab Emirates Antiviral Drugs Market Company Share Analysis
| Company Name |
|
||
| Teva Pharmaceutical Industries Ltd. | |||
| Pfizer Inc. | |||
| Gilead Sciences, Inc. | |||
| GSK plc. | |||
| F. Hoffmann-La Roche Ltd. | |||
United Arab Emirates Antiviral Drugs Market Geographical Sales Distribution, 2018-2032 USD Million
United Arab Emirates Antiviral Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The United Arab Emirates Antiviral Drugs Market is segmented based on Segmentation End User,Distribution Channel,Products,Drug,Indication,Patient.
United Arab Emirates Antiviral Drugs Market was valued at USD 245.51(Revenue in USD Million) in 2021.
United Arab Emirates Antiviral Drugs Market is projected to grow at a CAGR of 4.02% during the forecast period of 2024 to 2032.
The Topical segment is expected to dominate the United Arab Emirates Antiviral Drugs Market, holding a largest market share of 245.51 USD Million in 2024
United Arab Emirates Antiviral Drugs Market Scope
United Arab Emirates Antiviral Drugs Market Segmentation & Scope
End User
- Others
- Home Healthcare
- Clinics
- Ambultatory Centres
- Speciality Centers
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Products
- Parenteral
- Oral
- Topical
Drug
- Branded
- Generic
Indication
- Others
- Coronavirus Infection
- Respiratory Syncytial Virus
- Hepatitis B Virus
- Varicella-Zoster Virus (VZV)
- Human Cytomegalovirus (HCMV)
- Herpes Simplex Virus
- Hepatitis C Virus
- Human Immunodeficiency Virus (HIV)
- Influenza
Patient
- Adult
- Child
- Geriatric
Frequently Asked Questions
The United Arab Emirates Antiviral Drugs Market is segmented based on Segmentation End User,Distribution Channel,Products,Drug,Indication,Patient.
United Arab Emirates Antiviral Drugs Market was valued at USD 245.51(Revenue in USD Million) in 2021.
United Arab Emirates Antiviral Drugs Market is projected to grow at a CAGR of 4.02% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Antiviral Drugs Market for final year is USD 307.48 (USD Million).
United Arab Emirates Antiviral Drugs Market Company Profiling
Frequently Asked Questions
The United Arab Emirates Antiviral Drugs Market is segmented based on Segmentation End User,Distribution Channel,Products,Drug,Indication,Patient.
United Arab Emirates Antiviral Drugs Market was valued at USD 245.51(Revenue in USD Million) in 2021.
United Arab Emirates Antiviral Drugs Market is projected to grow at a CAGR of 4.02% during the forecast period of 2024 to 2032.
The estimated market value of the United Arab Emirates Antiviral Drugs Market for final year is USD 307.48 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.